Enzon Pharmaceuticals, Inc. - ENZN- Profile

Enzon Pharmaceuticals, Inc.. The Group's principal activity is to develop, manufacture and sell human therapeutics for life-threatening diseases. The Group includes three segments: Product sale which manufactures markets and sells pharmaceutical products for patients with cancer and other life-threatening diseases. Royalties, a source of revenue which is derived from sales of marketed products from PEG-INTRON, PEGASYS and MACUGEN that utilize our proprietary technology. Contract Manufacturing, where we utilize a portion of our excess manufacturing capacity to provide contract manufacturing services for a number of injectable products, such as single- and dual-chamber vial filling and lipid Complex formulations. The Group's products include ABELCET, ADAGEN, DEPOCYT and ONCASPAR. Product sale accounted for 54% of 2006 revenues; Royalties, 38% and Contract Manufacturing, 8%